Gabriel Filipe Rodrigues Silva Barboza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Gabriel Filipe Rodrigues Silva Barboza has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Marli Do Carmo Cupertino
Structural Biology Laboratory, Department of General Biology, Universidade Federal de Viçosa, Viçosa, Brazil
2 shared publications - Adriano Simões Barbosa Castro
Pharmacist-Biochemist at the Department of Medicine and Nursing of the Federal University of Viçosa (UFV); Professor of medicine at the Piranga Valley Dynamic College (FADIP) Viçosa, Minas Gerais, Brazil
1 shared publication - Ana Laura Matoso da Fonseca
Medical student at Faculdade Dinâmica do Vale do Piranga (FADIP) Ponte Nova, Minas Gerais, Brazil
1 shared publication Antônio Ferreira
Department of General Biology, Department of Medicine and Nursing Federal University of Viçosa (UFV) Viçosa Minas Gerais Brazil
1 shared publication- Gabriela Souza Carvalho
Medical student at Faculdade Dinâmica do Vale do Piranga (FADIP) Ponte Nova, Minas Gerais, Brazil
1 shared publication - José Carlos Rodrigues Duarte
Medical student at Faculdade Dinâmica do Vale do Piranga (FADIP) Ponte Nova, Minas Gerais, Brazil
1 shared publication
Latest Publications
- Open Access
- 4 November 2025
- Published by Revista Brasileira de Neurologia in Revista Brasileira de Neurologia
- Vol. 61 (3)
Melatonin Use in Children and Adolescents
The widespread availability of melatonin without a prescription, combined with the lack of specific medications for certain disorders with increasing morbidity rates, is significant factors driving the rise in melatonin use over the past decade. Despite its growing popularity, uncertainties surrounding optimal dosage and duration of exposure remain critical concerns, as these factors could increase the risk of overexposure and adverse effects. This study aims to update the therapeutic indications for melatonin, as well as assess its prescription, and therapeutic strategies. An updated search was conducted utilizing the descriptors (melatonin AND (children OR child OR adolescent)). Results presents melatonin's use for sleep disorders, autism spectrum disorder, neurodevelopmental disorders, and Attention Deficit/Hyperactivity Disorder, along with a smaller number of studies exploring its therapeutic potential in conditions such as atopic dermatitis, obesity, functional abdominal pain disorders, Bipolar Affective Disorder, neurogenetic syndromes, and Bourneville disease. Pediatric-appropriate prolonged-release melatonin in correct dosages has demonstrated positive results in clinical trials and appears to be the predominant formulation. The dosage adjustment phase is crucial for successful treatment. Significant variations in dosage, adaptation time, and exposure time were observed across clinical trials, complicating the comparison of results.
- 4 November 2025
- Published by Revista Brasileira de Neurologia in Revista Brasileira de Neurologia
- Vol. 61 (3)
Open AccessMelatonin Use in Children and Adolescents
The widespread availability of melatonin without a prescription, combined with the lack of specific medications for certain disorders with increasing morbidity rates, is significant factors driving the rise in melatonin use over the past decade. Despite its growing popularity, uncertainties surrounding optimal dosage and duration of exposure remain critical concerns, as these factors could increase the risk of overexposure and adverse effects. This study aims to update the therapeutic indications for melatonin, as well as assess its prescription, and therapeutic strategies. An updated search was conducted utilizing the descriptors (melatonin AND (children OR child OR adolescent)). Results presents melatonin's use for sleep disorders, autism spectrum disorder, neurodevelopmental disorders, and Attention Deficit/Hyperactivity Disorder, along with a smaller number of studies exploring its therapeutic potential in conditions such as atopic dermatitis, obesity, functional abdominal pain disorders, Bipolar Affective Disorder, neurogenetic syndromes, and Bourneville disease. Pediatric-appropriate prolonged-release melatonin in correct dosages has demonstrated positive results in clinical trials and appears to be the predominant formulation. The dosage adjustment phase is crucial for successful treatment. Significant variations in dosage, adaptation time, and exposure time were observed across clinical trials, complicating the comparison of results.
- Open Access
- 14 October 2025
- Published by Wiley in Photochemistry and Photobiology
- Vol. 102 (4) , 780-796
Prolonged exposure to artificial light and carcinogenesis: A systematic review of oncostatic mechanisms associated with melatonin pathways
Light pollution from widespread artificial illumination affects photosensitive organisms, including humans. Prolonged exposure to artificial light at night (ALAN), particularly blue light, is associated with melatonin suppression and circadian disruption, both implicated in carcinogenesis. This systematic review investigated the relationship between extended ALAN exposure and malignant neoplasms, identifying associated cancer types and biological mechanisms. A search was conducted in PubMed/Medline and Scopus using PRISMA guidelines. Original studies evaluating associations between ALAN, light pollution, or blue light and cancer in humans were included. Eighteen studies demonstrated a positive link between ALAN and breast cancer, with mechanisms involving interference in the cell cycle, DNA repair, oxidative stress, and activation of oncogenic pathways. Night‐shift work correlated with increased breast cancer risk, reduced melatonin levels, and hormonal dysregulation. Exogenous melatonin showed oncostatic potential, reversing epigenetic changes induced by ALAN and reducing tumor burden. Melatonin suppression may promote tumor progression through circadian gene disruption and hormonal imbalance. While findings support a consistent link between ALAN exposure and oncogenesis—especially breast and prostate cancers—methodological variability and confounding factors, such as genetic predisposition and lifestyle, limit generalization. Further studies are needed to clarify mechanisms and explore preventive strategies, including light pollution control and melatonin‐based interventions.
- 14 October 2025
- Published by Wiley in Photochemistry and Photobiology
- Vol. 102 (4) , 780-796
Open AccessProlonged exposure to artificial light and carcinogenesis: A systematic review of oncostatic mechanisms associated with melatonin pathways
Light pollution from widespread artificial illumination affects photosensitive organisms, including humans. Prolonged exposure to artificial light at night (ALAN), particularly blue light, is associated with melatonin suppression and circadian disruption, both implicated in carcinogenesis. This systematic review investigated the relationship between extended ALAN exposure and malignant neoplasms, identifying associated cancer types and biological mechanisms. A search was conducted in PubMed/Medline and Scopus using PRISMA guidelines. Original studies evaluating associations between ALAN, light pollution, or blue light and cancer in humans were included. Eighteen studies demonstrated a positive link between ALAN and breast cancer, with mechanisms involving interference in the cell cycle, DNA repair, oxidative stress, and activation of oncogenic pathways. Night‐shift work correlated with increased breast cancer risk, reduced melatonin levels, and hormonal dysregulation. Exogenous melatonin showed oncostatic potential, reversing epigenetic changes induced by ALAN and reducing tumor burden. Melatonin suppression may promote tumor progression through circadian gene disruption and hormonal imbalance. While findings support a consistent link between ALAN exposure and oncogenesis—especially breast and prostate cancers—methodological variability and confounding factors, such as genetic predisposition and lifestyle, limit generalization. Further studies are needed to clarify mechanisms and explore preventive strategies, including light pollution control and melatonin‐based interventions.